Whipplewood Advisors, LLC Vaxcyte, Inc. Transaction History
Whipplewood Advisors, LLC
- $169 Billion
- Q1 2025
A detailed history of Whipplewood Advisors, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Whipplewood Advisors, LLC holds 6 shares of PCVX stock, worth $207. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6
Previous 345
98.26%
Holding current value
$207
Previous $28.2 Million
69.11%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding PCVX
# of Institutions
345Shares Held
136MCall Options Held
348KPut Options Held
250K-
Ra Capital Management, L.P. Boston, MA12.2MShares$422 Million9.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$417 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.8MShares$408 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$344 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA6.42MShares$222 Million0.05% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.06B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...